Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?
M Cruz-Monteagudo, JL Medina-Franco… - Drug Discovery …, 2014 - Elsevier
Highlights•We provide a critical review of the current state of the activity cliff research.•We
comment on and integrate the opinions of experts working on activity cliffs.•The negative …
comment on and integrate the opinions of experts working on activity cliffs.•The negative …
On exploring structure–activity relationships
R Guha - In silico models for drug discovery, 2013 - Springer
Understanding structure–activity relationships (SARs) for a given set of molecules allows
one to rationally explore chemical space and develop a chemical series optimizing multiple …
one to rationally explore chemical space and develop a chemical series optimizing multiple …
Exploring activity cliffs in medicinal chemistry: miniperspective
D Stumpfe, J Bajorath - Journal of medicinal chemistry, 2012 - ACS Publications
In recent years, structure− activity relationships (SARs) have increasingly been studied
through mining of large compound data sets, leading to a renaissance of the activity …
through mining of large compound data sets, leading to a renaissance of the activity …
Expanding the medicinally relevant chemical space with compound libraries
F López-Vallejo, MA Giulianotti, RA Houghten… - Drug discovery today, 2012 - Elsevier
Analysis of marketed drugs and commercial vendor libraries used in high-throughput
screening suggests that the medicinally relevant chemical space may be expanded to …
screening suggests that the medicinally relevant chemical space may be expanded to …
Predicting protein-ligand interactions based on bow-pharmacological space and Bayesian additive regression trees
Identifying potential protein-ligand interactions is central to the field of drug discovery as it
facilitates the identification of potential novel drug leads, contributes to advancement from …
facilitates the identification of potential novel drug leads, contributes to advancement from …
Scanning Structure–Activity Relationships with Structure–Activity Similarity and Related Maps: From Consensus Activity Cliffs to Selectivity Switches
JL Medina-Franco - Journal of chemical information and modeling, 2012 - ACS Publications
Systematic description of structure–activity relationships (SARs) of data sets and structure–
property relationships (SPRs) is of paramount importance in medicinal chemistry and other …
property relationships (SPRs) is of paramount importance in medicinal chemistry and other …
Simplified, interpretable graph convolutional neural networks for small molecule activity prediction
We here present a streamlined, explainable graph convolutional neural network (gCNN)
architecture for small molecule activity prediction. We first conduct a hyperparameter …
architecture for small molecule activity prediction. We first conduct a hyperparameter …
Chemoinformatics: a view of the field and current trends in method development
M Vogt, J Bajorath - Bioorganic & medicinal chemistry, 2012 - Elsevier
The chemoinformatics field continues to evolve at the interface between computer science
and chemistry. Chemical information and computational approaches in pharmaceutical …
and chemistry. Chemical information and computational approaches in pharmaceutical …
Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach
E López-López, O Rabal, J Oyarzabal… - Journal of Computer …, 2020 - Springer
In this work, we analyze the structure–activity relationships (SAR) of epigenetic inhibitors
(lysine mimetics) against lysine methyltransferase (G9a or EHMT2) using a combined …
(lysine mimetics) against lysine methyltransferase (G9a or EHMT2) using a combined …
Design and Diversity analysis of chemical libraries in drug discovery
DA Olmedo, AA Durant-Archibold… - … chemistry & high …, 2024 - ingentaconnect.com
Chemical libraries and compound data sets are among the main inputs to start the drug
discovery process at universities, research institutes, and the pharmaceutical industry. The …
discovery process at universities, research institutes, and the pharmaceutical industry. The …